|
|
|
|
FDA Experts Give Thumbs Down to Arpida, Targanta Antibiotics
By Donna Young Washington Editor COLLEGE PARK, Md.- Federal advisers Thursday said Arpida AG failed to show in clinical trials that its experimental antibiotic iclaprim was safe and effective for treating patients with complicated skin...
|
|
|
Avoid antibiotics for patients with acute cough
Results from a Europe-wide study, which included two research centres in Cardiff and Southampton, found although as many as 70% of patients attending UK practices were prescribed antibiotics for acute cough, there was no significant...
|
|
|
[external] Antibiotics: It's The Efficacy, Stupid
An FDA committee's vote on Targanta's oritavancin could have a big impact on drug development.It's not looking good for Targanta and its hospital antibiotic, oritavancin, after the meeting of an advisory committee to the Food and Drug...
|
|
|
Antibiotics can cause pervasive, persistant changes to microbiota in human gut
Medical Research News Using a novel technique developed by Mitchell Sogin of the Marine Biological Laboratory (MBL) to identify different types of bacteria, scientists have completed the most precise survey to date of how microbial...
|
|
|
Antibiotics can cause pervasive, persistant changes to microbiota in human gut
MBL, WOODS HOLE, MAUsing a novel technique developed by Mitchell Sogin of the (MBL) to identify different types of bacteria, scientists have completed the most precise survey to date of how microbial communities in the human gut respond to...
|
|
|
FDA: Targanta, Theravance Drugs Comparable to Older Antibiotics
Shares rose for Targanta Therapeutics Corp.and Theravance Inc. Monday after the FDA said in briefing documents that both firms' experimental intravenous antibiotics were comparable to older drugs in treating complicated skin and skin...
|
|
|
FDA: Targanta, Theravance Drugs Comparable to Older Antibiotics
_ FDA: Targanta, Theravance Drugs Comparable to Older Antibiotics.
|
|
|
FDA: Targanta, Theravance Drugs Comparable to Older Antibiotics
Shares rose for Targanta Therapeutics Corp.and Theravance Inc. Monday after the FDA said in briefing documents that both firms' experimental intravenous antibiotics were comparable to older drugs in treating complicated skin and skin...
|
|
|
The Path to Self-Destruction: How Antibiotics Kill Bacteria
Antibiotics revolutionized medicine without anyone knowing how the drugs actually work.Since the first antibiotics reached the pharmacy in the 1940s, researchers discovered that they target various pieces of machinery in bacterial...
|
|
|
Resisting Bug Resistance With New and Better Antibiotics
The emergence of antibiotic resistance has put pressure on scientists working to replace the increasingly ineffective therapies, while a potential epidemic threat moves to the forefront of their minds.It's not just about filling pipelines...
|
|
|
Resisting Bug Resistance With New and Better Antibiotics
The emergence of antibiotic resistance has put pressure on scientists working to replace the increasingly ineffective therapies, while a potential epidemic threat moves to the forefront of their minds.It's not just about filling pipelines...
|
|
|
The Path to Self-Destruction
Antibiotics revolutionized medicine without anyone knowing how the drugs actually work.Since the first antibiotics reached the pharmacy in the 1940s, researchers discovered that they target various pieces of machinery in bacterial...
|
|
|
The Medicare Hospital-Acquired Conditions Initiative Will Spur Increased Patient Screening and Potentially Inc
- (NewsRx.com) -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the Medicare Hospital-Acquired Conditions Initiative will have a significant impact on...
|
|
|
Medicines and Drugs to Treat Peptic Ulcers
What is an ulcer?An ulcer is damage to the inner lining (the mucosa) of the stomach or the upper part of the intestine (duodenum)? A bacterium, Helicobacter pylori, is the main cause of ulcers in this area. Antibiotics:- Several...
|
|
|
Maharashtra plans two more biotech parks at Khalapur, Alibag
Maharashtra, which already has two biotech parks - pharma-biotech park at Pune and agri-biotech park at Jalna - is planning to set up two more biotech parks in the state.Already, one is being developed at Khalapur, while another biotech...
|
|
|
Drug Maker Targets Infections That Are Resistant To Antibiotics
Hospitals can be dangerous places for sick people.Their wards can be a fatal mix of weakened immune systems and nasty bacteria that tolerate some of the strongest antibiotics. But that's created opportunities for Cubist Pharmaceuticals ...
|
|
|
Studies from M.C. Gaudiano et al further understanding of regulatory actions
- (NewsRx.com) -- Data detailed in 'An LC method for the simultaneous screening of some common counterfeit and sub-standard antibiotics Validation and uncertainty estimation' have been presented (see also Regulatory Actions)....
|
|
|
US Study Points to Strong New Class of Antibiotics
Three naturally occurring antibacterial compounds hold promise for a new class of antibiotics, offering hope for fresh weapons against infection at a time when older drugs are losing their punch, researchers report in the journal Cell.The...
|
|
|
Drug Maker Targets Infections That Are Resistant To Antibiotics
_ Drug Maker Targets Infections That Are Resistant To Antibiotics.
|
|
|
Headache Secondary to Epidural Abscess
The authors are affiliated with the department ment of pediatrics, division of infectious diseases, at Childrens Hospital at Montefiore and at Albert Einstein College of Medicine in the Bronx, NY.Dr Douvoyiannis is a fellow in pediatric...
|
|
|
Preventive measures are still the best strategy Aspiration syndromes: Pneumonia and pneumonitis key words: Asp
abstract: While the risk factors for aspiration pneumonia are similar to those for aspiration pneumonitis, the 2 syndromes have different presentations.Aspiration pneumonia tends to occur in older patients or in those with neurological...
|
|
|
Gilead to Topple GSK as the Top Player in the Anti-Infectives Drug Market in 2014
Stringent, Yet Ill-Defined, Approval Standards Make it Difficult for Companies to Bring Hospital Antibiotics to Market, According to a New Report from Decision Resources WALTHAM, Mass., Nov.12 /PRNewswire/ -- Decision Resources, one...
|
|
|
Gilead to Topple GSK as the Top Player in the Anti-Infectives Drug Market in 2014
Stringent, Yet Ill-Defined, Approval Standards Make it Difficult for Companies to Bring Hospital Antibiotics to Market, According to a New Report from Decision ResourcesWALTHAM, Mass., Nov.12 /PRNewswire/ -- Decision Resources, one...
|
|
|
Gilead to Topple GSK as the Top Player in the Anti-Infectives Drug Market in 2014
Stringent, Yet Ill-Defined, Approval Standards Make it Difficult for Companies to Bring Hospital Antibiotics to Market, According to a New Report from Decision Resources WALTHAM, Mass., Nov.12 /PRNewswire/ -- Decision Resources, one...
|
|
|
Blue Cross Foundation to Honor Health Leader Dr. David Wallinga
KSLA Health Connections Health 3rd Annual Health Leadership Award recognizes the impact of the environment on children's health EAGAN, Minn., Nov.10 /PRNewswire/ -- The Blue Cross and Blue Shield of Minnesota Foundation will honor David...
|
